These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21911748)

  • 1. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy.
    McVicar CM; Hamilton R; Colhoun LM; Gardiner TA; Brines M; Cerami A; Stitt AW
    Diabetes; 2011 Nov; 60(11):2995-3005. PubMed ID: 21911748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes.
    Zhang J; Wu Y; Jin Y; Ji F; Sinclair SH; Luo Y; Xu G; Lu L; Dai W; Yanoff M; Li W; Xu GT
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):732-42. PubMed ID: 18235022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of erythropoietin inhibits retinopathy in RCS rats.
    Shen W; Chung SH; Irhimeh MR; Li S; Lee SR; Gillies MC
    PLoS One; 2014; 9(8):e104759. PubMed ID: 25119659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
    Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
    Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy.
    Mowat FM; Gonzalez F; Luhmann UF; Lange CA; Duran Y; Smith AJ; Maxwell PH; Ali RR; Bainbridge JW
    Am J Pathol; 2012 Apr; 180(4):1726-39. PubMed ID: 22342523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence supporting a role for N-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Müller glia dysfunction and death in diabetic retinopathy.
    Yong PH; Zong H; Medina RJ; Limb GA; Uchida K; Stitt AW; Curtis TM
    Mol Vis; 2010 Dec; 16():2524-38. PubMed ID: 21151599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
    Kern TS; Miller CM; Du Y; Zheng L; Mohr S; Ball SL; Kim M; Jamison JA; Bingaman DP
    Diabetes; 2007 Feb; 56(2):373-9. PubMed ID: 17259381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice.
    Liu Y; Leo LF; McGregor C; Grivitishvili A; Barnstable CJ; Tombran-Tink J
    Mol Med; 2012 Dec; 18(1):1387-401. PubMed ID: 23019073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
    Joharapurkar A; Patel V; Kshirsagar S; Patel MS; Savsani H; Jain M
    Eur J Pharmacol; 2021 May; 899():174032. PubMed ID: 33753107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity.
    Saito Y; Geisen P; Uppal A; Hartnett ME
    Mol Vis; 2007 Jun; 13():840-53. PubMed ID: 17615545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology.
    Berner AK; Brouwers O; Pringle R; Klaassen I; Colhoun L; McVicar C; Brockbank S; Curry JW; Miyata T; Brownlee M; Schlingemann RO; Schalkwijk C; Stitt AW
    Diabetologia; 2012 Mar; 55(3):845-54. PubMed ID: 22143324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vasoreparative potential of endothelial colony-forming cells in the ischemic retina is enhanced by cibinetide, a non-hematopoietic erythropoietin mimetic.
    O'Leary OE; Canning P; Reid E; Bertelli PM; McKeown S; Brines M; Cerami A; Du X; Xu H; Chen M; Dutton L; Brazil DP; Medina RJ; Stitt AW
    Exp Eye Res; 2019 May; 182():144-155. PubMed ID: 30876881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.
    Feit-Leichman RA; Kinouchi R; Takeda M; Fan Z; Mohr S; Kern TS; Chen DF
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4281-7. PubMed ID: 16249509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.
    Si YF; Wang J; Guan J; Zhou L; Sheng Y; Zhao J
    Br J Pharmacol; 2013 Jun; 169(3):619-31. PubMed ID: 23488985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats.
    Zhu B; Wang W; Gu Q; Xu X
    Exp Eye Res; 2008 Feb; 86(2):375-82. PubMed ID: 18191124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
    Li J; Wang P; Ying J; Chen Z; Yu S
    Cell Physiol Biochem; 2016; 39(3):1196-208. PubMed ID: 27595397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.
    Xie H; Zhang C; Liu D; Yang Q; Tang L; Wang T; Tian H; Lu L; Xu JY; Gao F; Wang J; Jin C; Li W; Xu G; Xu GT; Zhang J
    Diabetologia; 2021 Jan; 64(1):211-225. PubMed ID: 33104828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
    Barber AJ; Antonetti DA; Gardner TW
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subretinal delivery of AAV2-mediated human erythropoietin gene is protective and safe in experimental diabetic retinopathy.
    Xu H; Zhang L; Gu L; Lu L; Gao G; Li W; Xu G; Wang J; Gao F; Xu JY; Yao J; Wang F; Zhang J; Xu GT
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1519-30. PubMed ID: 24508793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.